SG11201703704PA - Diagnosis and treatment of incipient diabetes - Google Patents

Diagnosis and treatment of incipient diabetes

Info

Publication number
SG11201703704PA
SG11201703704PA SG11201703704PA SG11201703704PA SG11201703704PA SG 11201703704P A SG11201703704P A SG 11201703704PA SG 11201703704P A SG11201703704P A SG 11201703704PA SG 11201703704P A SG11201703704P A SG 11201703704PA SG 11201703704P A SG11201703704P A SG 11201703704PA
Authority
SG
Singapore
Prior art keywords
diagnosis
treatment
incipient diabetes
incipient
diabetes
Prior art date
Application number
SG11201703704PA
Inventor
Madhu S Malo
Original Assignee
Madhu S Malo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madhu S Malo filed Critical Madhu S Malo
Publication of SG11201703704PA publication Critical patent/SG11201703704PA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/1203Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
    • A23C9/1216Other enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06Enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/465Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/03Phosphoric monoester hydrolases (3.1.3)
    • C12Y301/03001Alkaline phosphatase (3.1.3.1)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
SG11201703704PA 2015-01-09 2015-11-17 Diagnosis and treatment of incipient diabetes SG11201703704PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562101751P 2015-01-09 2015-01-09
PCT/US2015/061017 WO2016111752A1 (en) 2015-01-09 2015-11-17 Diagnosis and treatment of incipient diabetes

Publications (1)

Publication Number Publication Date
SG11201703704PA true SG11201703704PA (en) 2017-06-29

Family

ID=56356286

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201703704PA SG11201703704PA (en) 2015-01-09 2015-11-17 Diagnosis and treatment of incipient diabetes

Country Status (10)

Country Link
US (1) US10781470B2 (en)
EP (1) EP3242954A4 (en)
JP (1) JP2018509885A (en)
KR (1) KR20170103865A (en)
CN (1) CN107109465A (en)
AU (1) AU2015375466A1 (en)
BR (1) BR112017014419A2 (en)
CA (1) CA2967377A1 (en)
SG (1) SG11201703704PA (en)
WO (1) WO2016111752A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018027179A1 (en) * 2016-08-04 2018-02-08 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions and methods to detect gastrointestinal disease
US11953501B2 (en) 2016-08-04 2024-04-09 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions and methods to detect gastrointestinal disease
CA3087569A1 (en) * 2018-01-09 2019-07-18 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
CN113645846A (en) * 2019-02-04 2021-11-12 路易斯安娜州立大学监测委员会, 农业和机械学院 Compositions and methods for detecting gastrointestinal disorders
WO2021011754A1 (en) * 2019-07-18 2021-01-21 Synthetic Biologics, Inc. Intestinal alkaline phosphatase-based treatments of metabolic disorders
CN111289456B (en) * 2020-03-31 2023-04-07 西安交通大学第二附属医院 Method for detecting intestinal alkaline phosphatase IAP in feces and intestinal tissues
CN112086194A (en) * 2020-09-14 2020-12-15 东南大学附属中大医院 New-onset type 2diabetes scoring prediction system
CN112394102B (en) * 2020-11-05 2023-05-26 上海交通大学医学院附属瑞金医院 Marker for detecting hypopituitarism and application thereof
KR102583808B1 (en) * 2021-03-05 2023-09-26 경희대학교 산학협력단 Method and kit for diagnosing diabetes using tear samples
WO2023230468A1 (en) * 2022-05-24 2023-11-30 Theriva Biologics, Inc. Ulcerative colitis treatments in selected patients

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0281251A3 (en) * 1987-02-04 1988-09-28 International Immunoassay Laboratories, Inc. A method for preparing a fecal sample composition for immunoassay testing
JP4353799B2 (en) * 2001-10-09 2009-10-28 ザ・ジョーンズ・ホプキンス・ユニバーシティ Phosphatase associated with metastasis
US20040096923A1 (en) * 2002-11-15 2004-05-20 Echelon Biosciences Incorporated Lipid phosphatase assays in disease and drug discovery
JP4999467B2 (en) * 2004-02-04 2012-08-15 ファルマアウェア セプシス ビー.ブイ. Use of alkaline phosphatase to detoxify LPS present at the mucosal barrier
BRPI0620751A2 (en) * 2005-12-28 2018-07-24 Hills Pet Nutrition Inc method for diagnosing a bodyweight condition or predisposition to a bodyweight condition in an animal, for selecting a regimen for an animal, for evaluating the effectiveness of a regimen for controlling a bodyweight condition or predisposition in an animal, for diagnosing a predisposition to an obesity-related health disorder in a method for diagnosing a bodyweight condition or predisposition to an animal bodyweight condition, to select a regimen for an animal, to detect the onset of a bodyweight condition or predisposition in an animal, to assess the effectiveness of a regimen for controlling a body weight condition or predisposition in an animal, to diagnose a predisposition to a related health disorder such as obesity in an animal, and to quantify a body condition indicator of an animal, and kit
US20110206654A1 (en) * 2008-08-29 2011-08-25 The General Hospital Corporation Methods of Modulating Gastrointestinal Tract Flora Levels with Alkaline Phosphatase
WO2010042903A1 (en) 2008-10-09 2010-04-15 Alfagene Bioscience, Inc Use and identification of biomarkers for gastrointestinal diseases
WO2012054057A1 (en) * 2010-10-22 2012-04-26 Zoltan Kiss Consulting Alkaline phosphatase to correct insulin resistance, hyperinsulinemia, and dyslipidemia
WO2012078308A1 (en) * 2010-11-10 2012-06-14 Halushka Perry V Devices and methods for concentration and analysis of fluids

Also Published As

Publication number Publication date
CN107109465A (en) 2017-08-29
BR112017014419A2 (en) 2018-01-16
JP2018509885A (en) 2018-04-12
CA2967377A1 (en) 2016-07-14
EP3242954A4 (en) 2018-09-26
AU2015375466A1 (en) 2017-05-25
WO2016111752A1 (en) 2016-07-14
EP3242954A1 (en) 2017-11-15
US20160201110A1 (en) 2016-07-14
KR20170103865A (en) 2017-09-13
US10781470B2 (en) 2020-09-22

Similar Documents

Publication Publication Date Title
IL252839A0 (en) Treatment of pemphigus
SG11201703704PA (en) Diagnosis and treatment of incipient diabetes
EP3152321A4 (en) Diagnosis and treatment of invasive aspergillosis
FI3789501T3 (en) Method for diagnostics, treatment and prevention of parkinson s disease
EP3104776A4 (en) Diagnosis and treatment of respiratory disorders
EP3215219C0 (en) Skin treatment system
HUE041700T2 (en) Lncrnas for therapy and diagnosis of cardiac hypertrophy
GB201413357D0 (en) Antibodies for treatment and diagnosis
PL3285636T3 (en) Phoropter system and method of use
HK1251265A1 (en) Diagnosis and treatment of infectious disease
ZA201900669B (en) Diagnosis, treatment and prevention of neurotensin receptor-related conditions
HK1255691A1 (en) Methods for histological diagnosis and treatment of diseases
HK1244821A1 (en) Peptides for use in treatment and diagnosis of type 1 diabetes
GB201500875D0 (en) Antibodies for treatment and diagnosis
GB201510676D0 (en) Novel diagnostic and therapeutic method
GB201411616D0 (en) Diagnosis and treatment of neurodegenerative disorders
GB2527046B (en) Device and method for the treatment of crops
HK1251021A1 (en) Diagnosis and treatment of mers-related renal disease
GB201509658D0 (en) Method of diagnosis
GB201404265D0 (en) Respiratory analysis and treatment
GB201401806D0 (en) Novel methods for diagnosis and therapy
GB201410118D0 (en) Early diagnosis of leptospire
GB201615274D0 (en) Citrullinated pertides for diagnosis or treatment of diabetes
PL3334479T3 (en) Blood treatment device
GB201621945D0 (en) Method of diagnosis